China Resources Sanjiu Medical & Pharmaceutical (SHE:000999) will invest up to 10 billion yuan in bank wealth management products and structured deposits.
The funds will be placed in fixed-income, low- to medium-risk products with terms of up to six months, according to a Thursday filing with the Shenzhen bourse.
The plan runs from shareholder approval until October 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments